Concepedia
Statistics
Publications
18
Citations
583
H-Index
14
Active since
1980
Affiliations
Massachusetts General Hospital(Current)
Dana-Farber Cancer Institute
Australian National University
D. P. Ryan is an author at Massachusetts General Hospital specializing in medicine, oncology, and pharmacology.
Publications per year
1980–2011
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies.
D. P. Ryan, Jeffrey G. Supko, J. P. Eder et al. · PubMed · 2001 · 116 citations
Medicine, Oncology, Pharmacology +15
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer
J. A. Meyerhardt, Keith Stuart, Christiane Fuchs et al. · Annals of Oncology · 2007 · 78 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
The colonization of the Pacific: the story according to human leukocyte antigens.
S. W. Serjeantson, D. P. Ryan, Arthur R. Thompson · PubMed · 1982 · 58 citations
Life Sciences, Anthropology, Immunology +12
Phase II trial of docetaxel, cisplatin, irinotecan, and bevacizumab in metastatic esophagogastric cancer
Peter C. Enzinger, D. P. Ryan, Eileen Regan et al. · Journal of Clinical Oncology · 2008 · 41 citations
Medicine, Oncology, Pharmacology +17
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery
Coen Klos, Paul C. Shellito, David W. Rattner et al. · The American Journal of Surgery · 2010 · 37 citations · Full text
Medicine, Oncology, Surgery +17
1–5 of 18